These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11225606)

  • 21. The design of prophylactic trials for HIV: the case of microbicides.
    Stein ZA; Myer L; Susser M
    Epidemiology; 2003 Jan; 14(1):80-3; discussion 83-4. PubMed ID: 12500050
    [No Abstract]   [Full Text] [Related]  

  • 22. Sharing Objective Measures of Adherence to a Vaginal Microbicide Promotes Candor About Actual Use and Bolsters Motivation to Prevent HIV.
    Kutner BA; Giguere R; Lentz C; Kajura-Manyindo C; Dolezal C; Butheliezi S; Gwande M; Nampiira S; Ndlovu T; Mvinjelwa P; Mwenda W; Balán IC
    AIDS Behav; 2021 Mar; 25(3):721-731. PubMed ID: 32920652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbicides 2000 conference. Welcoming remarks. Microbicides: global opportunities.
    Piot P
    AIDS; 2001 Feb; 15 Suppl 1():S4. PubMed ID: 11228108
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV prevention research: the ecstasy and the agony.
    Cates W; Feldblum P
    Lancet; 2008 Dec; 372(9654):1932-3. PubMed ID: 19059036
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaginal microbicides: moving ahead after an unexpected setback.
    van de Wijgert JH; Shattock RJ
    AIDS; 2007 Nov; 21(18):2369-76. PubMed ID: 18025873
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti HIV gel shows no promise in clinical trial.
    AORN J; 2009 Apr; 89(4):748. PubMed ID: 19434949
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
    Chen FH
    AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV topical microbicides: the current development strategy is fully justified.
    Stone AB
    Am J Public Health; 2004 Nov; 94(11):1845-6; author reply 1846-7. PubMed ID: 15514217
    [No Abstract]   [Full Text] [Related]  

  • 29. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
    Marais D; Gawarecki D; Allan B; Ahmed K; Altini L; Cassim N; Gopolang F; Hoffman M; Ramjee G; Williamson AL
    Antivir Ther; 2011; 16(8):1219-26. PubMed ID: 22155903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific microbicides in the prevention of HIV infection.
    Kelly CG; Shattock RJ
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The slow evolution of microbicides for STD/HIV prevention.
    Howes J; Bass M
    J Gend Specif Med; 1999; 2(3):22-3. PubMed ID: 11252848
    [No Abstract]   [Full Text] [Related]  

  • 32. The development of vaginal microbicides for the prevention of HIV transmission.
    Weber J; Desai K; Darbyshire J;
    PLoS Med; 2005 May; 2(5):e142. PubMed ID: 15916473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. News from the Society for Women's Health Research: seeking effective topical microbicides.
    Greenberger P
    J Womens Health Gend Based Med; 2001 Mar; 10(2):99-100. PubMed ID: 11268294
    [No Abstract]   [Full Text] [Related]  

  • 34. Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently: response to Smith et al. (2005).
    Foss AM; Watts CH; Vickerman PT; Heise L
    AIDS; 2006 Jan; 20(2):303-5. PubMed ID: 16511432
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV trial doomed by design, say critics.
    Check E
    Nature; 2007 Jul; 448(7150):110-1. PubMed ID: 17625525
    [No Abstract]   [Full Text] [Related]  

  • 36. Critically engaging: integrating the social and the biomedical in international microbicides research.
    Montgomery CM; Pool R
    J Int AIDS Soc; 2011 Sep; 14 Suppl 2(Suppl 2):S4. PubMed ID: 21968091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say.
    Moon MW; Khumalo-Sakutukwa GN; Heiman JE; Mbizvo MT; Padian NS
    J Transcult Nurs; 2002 Jan; 13(1):19-23. PubMed ID: 11776011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to Foss et al., 'Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently'.
    Wilson DP; Bodine EN; Smith RJ; Blower SM
    AIDS; 2005 Nov; 19(17):2044-6. PubMed ID: 16260916
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV genital shedding and safety of Carraguard use by HIV-infected women: a crossover trial in Thailand.
    McLean CA; van de Wijgert JH; Jones HE; Karon JM; McNicoll JM; Whitehead SJ; Braunstein S; Achalapong J; Chaikummao S; Tappero JW; Markowitz LE; Kilmarx PH
    AIDS; 2010 Mar; 24(5):717-22. PubMed ID: 20098295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbicides: ideas flourish, money to follow?
    Stephenson J
    JAMA; 2000 Apr; 283(14):1811-2. PubMed ID: 10770130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.